# Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

> **NCT02688868** · NA · COMPLETED · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** FirehawkTM 2.25mm

## Key facts

- **NCT ID:** NCT02688868
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2020-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688868, "Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02688868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*